The NYSCF – Druckenmiller Fellowship Program supports the most talented postdoctoral scientists at critical junctures in their careers who are in the pursuit of innovative and...
The Context: CRISPR is a powerful, ‘word-processor’-like tool for editing DNA, but currently it is much easier to eliminate undesired sequences than it is to accurately...
The Context: What makes stem cells special is their ability to turn into other cell types in the body (a characteristic called “pluripotency”). Our understanding of...
The Context: Age-related macular degeneration (AMD) is a disease which affects 8 million Americans and can lead to severe vision loss due to death of retinal...
Perhaps in the past few years, you’ve started to hear more about CRISPR gene editing— the revolutionary technique that allows us to precisely manipulate the DNA...
“Who thinks I can power this lightbulb with just the electricity from my finger?” Dr. Cecile Terrenoire asks a crowded room of eager students. About half...
The Context: It is estimated that 15 million babies are born prematurely each year, and a common premature birth complication is low oxygen levels. We know...
“After 3.8 billion years of evolving by Darwinian principles, we are turning a corner and taking more control over all biology, including our own,” explained Jamie...
The Context: Patients suffering from stroke, paralysis, ALS, Parkinson’s, and many other conditions are often left with impaired speaking and gesturing abilities, and there are few...
“Stem cells allow us to understand what exactly is broken, and therefore, what needs to be fixed,” NYSCF CEO Susan L. Solomon explained. “The problem with...
“I got involved in type one diabetes advocacy over 25 years ago when my son was diagnosed,” said NYSCF CEO Susan L. Solomon, JD. “At that...
The Context: The brain has “thirst neurons” that help us know when we need water and when we don’t. But how these neurons receive information from...
Women’s reproductive cancers—such as ovarian cancer, endometrial cancer, uterine cancer, and cervical cancer—are especially difficult to treat. Mortality rates are high (32,000 women die from these...
The New York Stem Cell Foundation Research Institute is recruiting for a stem cell research study. Eligible individuals will have type 1 diabetes. The purpose of...
Maria Themeli, MD, PhD, believes that everyone, no matter their financial situation, should have access to effective cancer treatments. Because of this, she is working to...
NYSCF – Robertson Stem Cell Investigator, CRISPR pioneer, and MIT Professor of Brain and Cognitive Sciences and Biological Engineering Dr. Feng Zhang and his collaborators have...
Building a strong community of researchers committed to advancing cutting-edge science is critical for getting treatments and cures to patients as quickly as possible. Because of...
“At the current rate of therapeutic development for rare diseases, it will be 2000 years before doctors won’t have to say to patients, ‘There’s nothing more...
“We had the foundational tools we needed to move our research from academia to biotech,” remarked NYSCF – Robertson Investigator Alumnus Dr. Paul Tesar. “We had...
The Context: In multiple sclerosis, the immune system attacks myelin (the fatty substance that surrounds neurons and helps them send signals). Currently, there are no...
The Context: The brain activity that enables the rapid back-and-forth of human conversation is likely disrupted in diseases or disorders that interfere with normal communication such...
44 million people worldwide are affected by Alzheimer’s. 1 in 3 seniors will die with it or a related dementia. The cost of treating Alzheimer’s is...
This morning, NYSCF CEO Susan L. Solomon rang the NASDAQ bell to officially open stock trading for the day. “I’m incredibly optimistic about the future of...
This month, NYSCF CEO Susan L. Solomon, JD, spoke at the NYC Builds Bio+ February Quarterly Breakfast (held at the New York Genome Center) about NYSCF’s...
Curing disease takes more than just research– it requires well-planned investment and business strategies that allow science to get done and treatments to move out of...
